Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million PR Newswire - Wed Dec 17, 2025

HOLON, Israel , Dec. 17, 2025 /PRNewswire/ --  Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 2.24 (-5.08%)
Compugen: Q3 Earnings Snapshot AP - Mon Nov 10, 2025

Compugen: Q3 Earnings Snapshot

CGEN : 2.24 (-5.08%)
Compugen Reports Third Quarter 2025 Results PR Newswire - Mon Nov 10, 2025

HOLON, Israel , Nov. 10, 2025 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 2.24 (-5.08%)
Compugen to Participate in Stifel 2025 Healthcare Conference PR Newswire - Tue Nov 4, 2025

HOLON, Israel , Nov. 4, 2025 /PRNewswire/ --  Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 2.24 (-5.08%)
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 PR Newswire - Mon Oct 27, 2025

HOLON, Israel , Oct. 27, 2025 /PRNewswire/ --  Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 2.24 (-5.08%)
Analysts Offer Insights on Healthcare Companies: Compugen (CGEN) and AbbVie (ABBV) Tipranks - Wed Oct 15, 2025

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compugen (CGEN – Research Report) and AbbVie (ABBV – Research Report) with bullish sentiments.Elevate...

CGEN : 2.24 (-5.08%)
ABBV : 213.38 (-0.45%)
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 PR Newswire - Mon Oct 13, 2025

HOLON, Israel , Oct. 13, 2025 /PRNewswire/ --  Compugen Ltd.  (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 2.24 (-5.08%)
Compugen to Present at SITC 2025 PR Newswire - Mon Oct 6, 2025

HOLON, Israel , Oct. 6, 2025 /PRNewswire/ -- Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery,...

CGEN : 2.24 (-5.08%)
Compugen to Present Research at the Single Cell Genomics 2025 Conference PR Newswire - Mon Sep 8, 2025

HOLON, ISRAEL , Sept. 8, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational...

CGEN : 2.24 (-5.08%)
Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire - Thu Aug 28, 2025

HOLON, Israel , Aug. 28, 2025 /PRNewswire/ --  Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational...

CGEN : 2.24 (-5.08%)

Barchart Exclusives

Why Cloudflare (NET) Stock Options Could Be Due for a Comeback Trade Barchart - 16 minutes ago
Although Cloudflare has struggled amid broader questions impacting the tech ecosystem, NET stock may surprisingly benefit from a reflexive swing higher. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot